Gibson Dunn & Crutcher advised AMPYR Energy USA on the transaction, Latham & Watkins and and McGuireWoods advised Crayhill Capital Management LLP. AMPYR Energy USA (“AMPYR...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Evergreen Environmental Partners Holdings, LLC on the transaction. Meridian Waste Acquisitions, LLC, a non-hazardous, integrated solid waste services company, announced the...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Rose advised Sixth Street. Arrowhead...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Veritas, while Davis Polk advised Verisk on the deal. Verisk announced the sale of its energy business, Wood Mackenzie, to an...
You must be a Standard 1 Year member to access this content.
